Brief: Cosmo Announces Successful Outcome Of Rifamycin 600Mg Phase II Trial In IBS-D

Cosmo NV

11/01/2021 06:05

Jan 11 (Reuters) - COSMO PHARMACEUTICALS NV  COPN.S :
    * ANNOUNCES SUCCESSFUL OUTCOME OF RIFAMYCIN 600MG PHASE II
TRIAL
IN IBS-D
    * TRIAL WAS VERY SUCCESSFUL NOTWITHSTANDING DECISION BY
COSMO TO
REDUCE ENVISAGED SAMPLE SIZE BY 20% DUE TO COVID-19 RESTRICTIONS

Source text for Eikon:  ID:nTENcyq2na 
Further company coverage:  COPN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))